Shin-Etsu Chemical Co Ltd Unsponsored ADR AI Stock Analysis
Want to see SHECY full AI Analyst Report?
Shin-Etsu Chemical Co Ltd Unsponsored ADR (SHECY) AI Stock Analysis
Shin-Etsu Chemical Co Ltd Unsponsored ADR
(Other OTC:SHECY)
The overall score of 66 reflects a company with fortress-like financials and strong cash generation, offset by weak technical momentum and a fair but unexciting valuation. The balance sheet strength and free cash flow growth are the most significant positive factors, while the bearish technical trend below key moving averages and margin normalization from peak levels are the primary detractors.
Shin-Etsu Chemical Co Ltd Unsponsored ADR (SHECY) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $70.88B
- Dividend Yield
- 2.08%
- Average Volume (3M)
- 485.20K
- Price to Earnings (P/E)
- 21.0
- Beta (1Y)
- 1.13
- Revenue Growth
- -0.47%
- EPS Growth
- -0.52%
- Country
- US
- Employees
- 27,342
- Sector
- Basic Materials
- Sector Strength
- 61
- Industry
- Chemicals
Shin-Etsu Chemical Co Ltd Unsponsored ADR Business Overview & Revenue Model
Company Description
Shin-Etsu Chemical Co., Ltd. engages in the manufacture and sale of industrial chemicals. Its operations are carried out through the following segments: Living Environment Basic Materials Business, Electronic Materials Business, Functional Materials...
How the Company Makes Money
Shin-Etsu makes money by manufacturing and selling chemical and materials products to industrial customers worldwide, generating revenue primarily from product sales across several major business lines. A key earnings driver is its semiconductor mate...
Shin-Etsu Chemical Co Ltd Unsponsored ADR Financial Statement Overview
Summary
Shin-Etsu's financial foundation is exceptional, anchored by a nearly debt-free balance sheet (D/E 0.057) and robust cash flow generation with a 21.5% TTM free cash flow growth. Profitability remains high with a 33.9% gross margin and 18% net margin, though margins have normalized from FY2023 peaks. The primary risk is the downward trend in margins, but overall financial health is outstanding.
Income Statement
72PositiveBalance Sheet
95Very PositiveCash Flow
78Positive| Breakdown | TTM | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.59T | 2.56T | 2.73T | 2.41T | 2.81T | 2.07T |
| Gross Profit | 924.89B | 984.12B | 933.91B | 911.21B | 1.21T | 868.00B |
| EBITDA | 946.67B | 980.46B | 931.14B | 1.02T | 1.24T | 865.91B |
| Net Income | 500.04B | 534.02B | 503.07B | 520.14B | 708.24B | 500.12B |
Balance Sheet | ||||||
| Total Assets | 5.36T | 5.64T | 5.69T | 5.15T | 4.73T | 4.05T |
| Cash, Cash Equivalents and Short-Term Investments | 1.54T | 1.81T | 1.67T | 1.72T | 1.60T | 1.44T |
| Total Debt | 243.91B | 16.84B | 244.35B | 24.30B | 29.81B | 30.40B |
| Total Liabilities | 975.29B | 799.02B | 1.02T | 723.90B | 704.19B | 624.21B |
| Stockholders Equity | 4.22T | 4.66T | 4.48T | 4.26T | 3.87T | 3.33T |
Cash Flow | ||||||
| Free Cash Flow | 385.34B | 439.10B | 380.68B | 377.70B | 488.65B | 355.97B |
| Operating Cash Flow | 785.18B | 881.93B | 755.63B | 755.18B | 788.01B | 553.53B |
| Investing Cash Flow | -213.94B | -142.55B | -577.66B | -1.10T | -186.49B | -253.72B |
| Financing Cash Flow | -526.64B | -454.90B | -535.28B | -369.47B | -423.56B | -122.50B |
Shin-Etsu Chemical Co Ltd Unsponsored ADR Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SHECY, the sentiment is Negative. The current price of 17.84 is below the 20-day moving average (MA) of 18.31, below the 50-day MA of 18.65, and below the 200-day MA of 20.12, indicating a bearish trend. The MACD of -0.31 indicates Positive momentum. The RSI at 43.01 is Neutral, neither overbought nor oversold. The STOCH value of 57.62 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SHECY.
Shin-Etsu Chemical Co Ltd Unsponsored ADR Peers Comparison
Overall Rating
WLKP84Outperform
SHECY66Neutral
CE61Neutral
DOW60Neutral
DD55Neutral
BAK39Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 84Outperform | $764.29M | 12.69 | 15.70% | 8.89% | 9.40% | 20.34% | |
| 66Neutral | $71.55B | 20.99 | 11.28% | 2.08% | -0.47% | -0.52% | |
| Sector * | 61Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
| 61Neutral | $5.63B | 21.60 | 6.35% | 0.23% | 1.43% | ― | |
| 60Neutral | $24.00B | -26.22 | -4.50% | 4.24% | 4.16% | 20.86% | |
| 55Neutral | $20.50B | 68.35 | 2.18% | 1.56% | -43.45% | ― | |
| 39Underperform | $478.11M | -0.50 | 46.16% | ― | -1.40% | 2.39% |
* Basic Materials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| SHECY | Shin-Etsu Chemical Co Ltd Unsponsored ADR | 17.84 | 3.00 | 20.20% | |
| CE | Celanese | 51.41 | 14.57 | 39.54% | |
| BAK | Braskem Sa | 1.13 | -1.89 | -62.58% | |
| WLKP | Westlake Chemical Partners LP | 21.20 | 4.75 | 28.91% | |
| DD | DuPont de Nemours, Inc. | 153.78 | 39.84 | 34.96% | |
| DOW | Dow Inc. | 33.04 | 12.39 | 60.00% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 29, 2026
